Citations (55)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Jialei Hu, Lei Jiao, Yuemei Hu, Kai Chu, Jingxin Li, Fengcai Zhu, Taishun Li, Zhiyuan Wu, Dong Wei, Fanyue Meng & Bingxiang Wang. (2018) One year immunogenicity and safety of subunit plague vaccine in Chinese healthy adults: An extended open-label study. Human Vaccines & Immunotherapeutics 14:11, pages 2701-2705.
Read now
Read now
Kai Chu, Jialei Hu, Fanyue Meng, Jingxin Li, Li Luo, Jianjun Xu, Zhonghang Yuan, Zhiyong Li, Wangeng Chen, Lei Jiao, Yali Chang, Bingxiang Wang & Yuemei Hu. (2016) Immunogenicity and safety of subunit plague vaccine: A randomized phase 2a clinical trial. Human Vaccines & Immunotherapeutics 12:9, pages 2334-2340.
Read now
Read now
Qingwen Zhang, Qiong Wang, Guang Tian, Zhizhen Qi, Xuecan Zhang, Xiaohong Wu, Yefeng Qiu, Yujing Bi, Xiaoyan Yang, Youquan Xin, Jian He, Jiyuan Zhou, Lin Zeng, Ruifu Yang & Xiaoyi Wang. (2014) Yersinia pestis biovar Microtus strain 201, an avirulent strain to humans, provides protection against bubonic plague in rhesus macaques. Human Vaccines & Immunotherapeutics 10:2, pages 368-377.
Read now
Read now
Valentina A Feodorova, Lidiya V Sayapina, Michael J Corbel & Vladimir L Motin. (2014) Russian vaccines against especially dangerous bacterial pathogens. Emerging Microbes & Infections 3:1, pages 1-17.
Read now
Read now
Xiaoyi Wang, Xuecan Zhang, Dongsheng Zhou & Ruifu Yang. (2013) Live-attenuated Yersinia pestis vaccines. Expert Review of Vaccines 12:6, pages 677-686.
Read now
Read now
Valentina A Feodorova & Vladimir L Motin. (2012) Plague vaccines: current developments and future perspectives. Emerging Microbes & Infections 1:1, pages 1-5.
Read now
Read now
Articles from other publishers (49)
Ann Carpenter, Michelle A. Waltenburg, Aron Hall, James Kile, Marie Killerby, Barbara Knust, Maria Negron, Megin Nichols, Ryan M. Wallace, Casey Barton Behravesh & Jennifer H. McQuiston. (2022) Vaccine Preventable Zoonotic Diseases: Challenges and Opportunities for Public Health Progress. Vaccines 10:7, pages 993.
Crossref
Crossref
Wei Zhang, Xiaolin Song, Lina Zhai, Jianshu Guo, Xinying Zheng, Lili Zhang, Meng Lv, Lingfei Hu, Dongsheng Zhou, Xiaolu Xiong & Wenhui Yang. (2022) Complete Protection Against Yersinia pestis in BALB/c Mouse Model Elicited by Immunization With Inhalable Formulations of rF1-V10 Fusion Protein via Aerosolized Intratracheal Inoculation. Frontiers in Immunology 13.
Crossref
Crossref
Sergei Biryukov, Jennifer L. Dankmeyer, Zain Shamsuddin, Ivan Velez, Nathaniel O. Rill, Raysa Rosario-Acevedo, Christopher P. Klimko, Jennifer L. Shoe, Melissa Hunter, Michael D. Ward, Lisa H. Cazares, David P. Fetterer, Joel A. Bozue, Patricia L. Worsham, Christopher K. Cote & Kei Amemiya. (2021) Impact of Toll-Like Receptor-Specific Agonists on the Host Immune Response to the Yersinia pestis Plague rF1V Vaccine. Frontiers in Immunology 12.
Crossref
Crossref
Valentina A. Feodorova, Anna M. Lyapina, Maria A. Khizhnyakova, Sergey S. Zaitsev, Yury V. Saltykov & Vladimir L. Motin. (2020) Yersinia pestis Antigen F1 but Not LcrV Induced Humoral and Cellular Immune Responses in Humans Immunized with Live Plague Vaccine—Comparison of Immunoinformatic and Immunological Approaches. Vaccines 8:4, pages 698.
Crossref
Crossref
E. A. Krasil'nikova, A. S. Trunyakova, A. S. Vagaiskaya, T. E. Svetoch, R. Z. Shaikhutdinova & S. V. Dentovskaya. (2020) A search for new molecular targets for optimizing plague preventive vaccination and therapy. Russian Journal of Infection and Immunity 11:2, pages 265-282.
Crossref
Crossref
Xiuran Wang, Amit K. Singh & Wei Sun. (2020) Protection and Safety Evaluation of Live Constructions Derived from the Pgm− and pPCP1− Yersinia pestis Strain. Vaccines 8:1, pages 95.
Crossref
Crossref
Yuan-Chuan Chen, Shiu-Jau Chen, Hwei-Fang Cheng & Ming-Kung Yeh. (2020) Development of Yersinia pestis F1 antigen-loaded liposome vaccine against plague using microneedles as a delivery system. Journal of Drug Delivery Science and Technology 55, pages 101443.
Crossref
Crossref
David W. Pascual. 2020. Mucosal Vaccines. Mucosal Vaccines
445
460
.
Jae-Llane Ditchburn & Ryan Hodgkins. (2019) Yersinia pestis, a problem of the past and a re-emerging threat. Biosafety and Health 1:2, pages 65-70.
Crossref
Crossref
A L Carvalho, A Miquel-Clopés, U Wegmann, E Jones, R Stentz, A Telatin, N J Walker, W A Butcher, P J Brown, S Holmes, M J Dennis, E D Williamson, S G P Funnell, M Stock & S R Carding. (2019) Use of bioengineered human commensal gut bacteria-derived microvesicles for mucosal plague vaccine delivery and immunization. Clinical & Experimental Immunology 196:3, pages 287-304.
Crossref
Crossref
Wei Sun & Amit K. Singh. (2019) Plague vaccine: recent progress and prospects. npj Vaccines 4:1.
Crossref
Crossref
Shailendra K. Verma, Ankit Gupta, Lalit Batra & Urmil Tuteja. (2019) Escherichia coli expressed flagellin C (FliC) of Salmonella Typhi improved the protective efficacy of YopE against plague infection. Vaccine 37:1, pages 19-24.
Crossref
Crossref
B.D. Moore, R.R.C. New, W. Butcher, R. Mahood, J. Steward, M. Bayliss, C. MacLeod, M. Bogus & E.D. Williamson. (2018) Dual route vaccination for plague with emergency use applications. Vaccine 36:34, pages 5210-5217.
Crossref
Crossref
Valentina A. Feodorova, Anna M. Lyapina, Maria A. Khizhnyakova, Sergey S. Zaitsev, Lidiya V. Sayapina, Tatiana E. Arseneva, Alexey L. Trukhachev, Svetlana A. Lebedeva, Maxim V. Telepnev, Onega V. Ulianova, Elena P. Lyapina, Sergey S. Ulyanov & Vladimir L. Motin. (2018) Humoral and cellular immune responses to Yersinia pestis Pla antigen in humans immunized with live plague vaccine. PLOS Neglected Tropical Diseases 12:6, pages e0006511.
Crossref
Crossref
Li Liu, Dong Wei, Zhe Qu, Li Sun, Yufa Miao, Yanwei Yang, Jinbiao Lu, Weixin Du, Bingxiang Wang & Bo Li. (2018) A safety and immunogenicity study of a novel subunit plague vaccine in cynomolgus macaques. Journal of Applied Toxicology 38:3, pages 408-417.
Crossref
Crossref
E. Diane Williamson & Petra C.F. Oyston. 2018. Plotkin's Vaccines. Plotkin's Vaccines
762
772.e4
.
Shailendra Kumar Verma & Urmil Tuteja. (2016) Plague Vaccine Development: Current Research and Future Trends. Frontiers in Immunology 7.
Crossref
Crossref
Wei Sun. 2016. Yersinia pestis: Retrospective and Perspective. Yersinia pestis: Retrospective and Perspective
313
360
.
Valentina A. Feodorova, Lidiya V. Sayapina & Vladimir L. Motin. 2016. Vaccine Design. Vaccine Design
487
498
.
Patricia Fellows, Jessica Price, Shannon Martin, Karen Metcalfe, Robert Krile, Roy Barnewall, Mary Kate Hart & Hank Lockman. (2015) Characterization of a Cynomolgus Macaque Model of Pneumonic Plague for Evaluation of Vaccine Efficacy. Clinical and Vaccine Immunology 22:9, pages 1070-1078.
Crossref
Crossref
Lalit Batra, Shailendra K. Verma, Durgesh P. Nagar, Nandita Saxena, Prachi Pathak, Satish C. Pant & Urmil Tuteja. (2014) HSP70 Domain II of Mycobacterium tuberculosis Modulates Immune Response and Protective Potential of F1 and LcrV Antigens of Yersinia pestis in a Mouse Model. PLoS Neglected Tropical Diseases 8:12, pages e3322.
Crossref
Crossref
Wei Sun, Shilpa Sanapala, Jeremy C. Henderson, Shandiin Sam, Joseph Olinzock, M. Stephen Trent & Roy CurtissIIIIII. (2014) LcrV Delivered via Type III Secretion System of Live Attenuated Yersinia pseudotuberculosis Enhances Immunogenicity against Pneumonic Plague. Infection and Immunity 82:10, pages 4390-4404.
Crossref
Crossref
Yujun Cui, Xianwei Yang, Xiao Xiao, Andrey P. Anisimov, Dongfang Li, Yanfeng Yan, Dongsheng Zhou, Minoarisoa Rajerison, Elisabeth Carniel, Mark Achtman, Ruifu Yang & Yajun Song. (2014) Genetic variations of live attenuated plague vaccine strains (Yersinia pestis EV76 lineage) during laboratory passages in different countries. Infection, Genetics and Evolution 26, pages 172-179.
Crossref
Crossref
V.A. Feodorova, M.A. Khizhnyakova, A.M. Lyapina, M.V. Telepnev, O.V. Ulianova, E.P. Lyapina & V.L. Motin. (2014) Selectivity in IgG Subclass Response to Live Plague Vaccine in Humans. Procedia in Vaccinology 8, pages 34-37.
Crossref
Crossref
Andrea M. Keane-Myers, Matt Bell, Drew Hannaman & Mark Albrecht. 2014. Electroporation Protocols. Electroporation Protocols
325
336
.
Wei Li, Shixia Wang & Shan Lu. (2013) Pilot Study on the Use of DNA Priming Immunization to Enhance Y. pestis LcrV-Specific B Cell Responses Elicited by a Recombinant LcrV Protein Vaccine. Vaccines 2:1, pages 36-48.
Crossref
Crossref
Jessica L. Price, T. Scott Manetz, Jeffry D. Shearer & Robert V. House. (2013) Preclinical Safety Assessment of a Recombinant Plague Vaccine (rF1V). International Journal of Toxicology 32:5, pages 327-335.
Crossref
Crossref
Pan Tao, Marthandan Mahalingam, Michelle L. Kirtley, Christina J. van Lier, Jian Sha, Linsey A. Yeager, Ashok K. Chopra & Venigalla B. Rao. (2013) Mutated and Bacteriophage T4 Nanoparticle Arrayed F1-V Immunogens from Yersinia pestis as Next Generation Plague Vaccines. PLoS Pathogens 9:7, pages e1003495.
Crossref
Crossref
S. V. Dentovskaya, P. Kh. Kopylov, S. A. Ivanov, S. A. Ageev & A. P. Anisimov. (2013) Molecular bases of vaccine-prevention of plague. Molecular Genetics, Microbiology and Virology 28:3, pages 87-98.
Crossref
Crossref
Kunal Kumar, Divya Awasthi, Seung-Yub Lee, Jason E. Cummings, Susan E. Knudson, Richard A. Slayden & Iwao Ojima. (2013) Benzimidazole-based antibacterial agents against Francisella tularensis. Bioorganic & Medicinal Chemistry 21:11, pages 3318-3326.
Crossref
Crossref
Jian Sha, Michelle L. Kirtley, Christina J. van Lier, Shaofei Wang, Tatiana E. Erova, Elena V. Kozlova, Anthony Cao, Yingzi Cong, Eric C. Fitts, Jason A. Rosenzweig & Ashok K. Chopra. (2013) Deletion of the Braun Lipoprotein-Encoding Gene and Altering the Function of Lipopolysaccharide Attenuate the Plague Bacterium. Infection and Immunity 81:3, pages 815-828.
Crossref
Crossref
V.A. Feodorova, A.M. Lyapina, M.V. Telepnev, M.A. Khizhnyakova, S.S. Konnova, E.P. Lyapina, L.V. Sayapina, O.V. Ulianova, T.I. Polyanina & V.L. Motin. (2013) YscF is a Highly Specific Marker for Evaluation of Antibody Response to Live Plague Vaccine in Humans. Procedia in Vaccinology 7, pages 44-48.
Crossref
Crossref
E. Diane Williamson & Petra C.F. Oyston. 2013. Vaccines. Vaccines
493
503
.
Mark T. Albrecht, Brian D. Livingston, John T. Pesce, Matt G. Bell, Drew Hannaman & Andrea M. Keane-Myers. (2012) Electroporation of a multivalent DNA vaccine cocktail elicits a protective immune response against anthrax and plague. Vaccine 30:32, pages 4872-4883.
Crossref
Crossref
Patricia Fellows, Winston Lin, Carol Detrisac, Shu-Chieh Hu, Narayanan Rajendran, Bruce Gingras, Louis Holland, Jessica Price, Mark Bolanowski & Robert V. House. (2012) Establishment of a Swiss Webster Mouse Model of Pneumonic Plague To Meet Essential Data Elements under the Animal Rule. Clinical and Vaccine Immunology 19:4, pages 468-476.
Crossref
Crossref
V.A. Feodorov, A.M. Lyapina, O.V. Ulianova, E.P. Lyapina, L.V. Sayapina, M.N. Lyapin, A.A. Shcherbakov, M.V. Telepnev & V.L. Motin. (2012) Serologic Markers for Long-Term Immunity in Humans Vaccinated with Live Yersinia pestis EV NIIEG. Procedia in Vaccinology 6, pages 10-13.
Crossref
Crossref
Theresa J. Ochoa & Miguel O’Ryan. 2012. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
823
828.e2
.
M.J. Corbel. 2012. Medical Microbiology. Medical Microbiology
350
358
.
Petra C.F. Oyston & E. Diane Williamson. 2012. Advances in Applied Microbiology Volume 81. Advances in Applied Microbiology Volume 81
209
241
.
Nobuyuki Matoba, Namrata Rahul Shah & Tsafrir S. Mor. (2011) Humoral immunogenicity of an HIV-1 envelope residue 649–684 membrane-proximal region peptide fused to the plague antigen F1-V. Vaccine 29:34, pages 5584-5590.
Crossref
Crossref
James Chesko, Chris Fox, Tim Dutill, Thomas Vedvick & Steve Reed. 2011. Development of Vaccines. Development of Vaccines
385
397
.
Jr-Shiuan Lin, Frank M. Szaba, Lawrence W. Kummer, Brett A. Chromy & Stephen T. Smiley. (2011)
Yersinia pestis
YopE Contains a Dominant CD8 T Cell Epitope that Confers Protection in a Mouse Model of Pneumonic Plague
. The Journal of Immunology 187:2, pages 897-904.
Crossref
Crossref
Petra Oyston & Diane Williamson. (2011) Plague: Infections of Companion Animals and Opportunities for Intervention. Animals 1:2, pages 242-255.
Crossref
Crossref
Yu. A. Knirel’, V. A. Fedorova & A. P. Anisimov. (2011) Struggling for control over the plague. Herald of the Russian Academy of Sciences 81:1, pages 35-43.
Crossref
Crossref
Richard Warren, Hank Lockman, Roy Barnewall, Robert Krile, Oscar Bermeo Blanco, Daphne Vasconcelos, Jessica Price, Robert V. House, Mark A. Bolanowksi & Patricia Fellows. (2011) Cynomolgus macaque model for pneumonic plague. Microbial Pathogenesis 50:1, pages 12-22.
Crossref
Crossref
Patricia Fellows, Jeffrey Adamovicz, Justin Hartings, Robert Sherwood, William Mega, Trevor Brasel, Ed Barr, Lou Holland, Winston Lin, Amanda Rom, William Blackwelder, Jessica Price, Stephen Morris, Doris Snow & Mary Kate Hart. (2010) Protection in mice passively immunized with serum from cynomolgus macaques and humans vaccinated with recombinant plague vaccine (rF1V). Vaccine 28:49, pages 7748-7756.
Crossref
Crossref
Ascención Torres-Escobar, María Dolores Juárez-Rodríguez, Christine G. Branger & Roy CurtissIIIIII. (2010) Evaluation of the humoral immune response in mice orally vaccinated with live recombinant attenuated Salmonella enterica delivering a secreted form of Yersinia pestis PsaA. Vaccine 28:36, pages 5810-5816.
Crossref
Crossref
V.A. Feodorova, L.N. Pan’kina, E.P. Savostina, O.S. Kuznetsov, N.P. Konnov, L.V. Sayapina, S. V. Dentovskaya, R.Z. Shaikhutdinova, S.A. Ageev, B. Lindner, A.N. Kondakova, O. Holst, G.B. Pier, Y.A. Knirel, A.P. Anisimov & V.L. Motin. 2010. The Challenge of Highly Pathogenic Microorganisms. The Challenge of Highly Pathogenic Microorganisms
261
268
.
V.A. Feodorova, L.N. Pan’kina, E.P. Savostina, O.S. Kuznetsov, N.P. Konnov, L.V. Sayapina, S.V. Dentovskaya, R.Z. Shaikhutdinova, S.A. Ageev, B. Lindner, A.N. Kondakova, N.A. Kocharova, S.N. Senchenkova, O. Holst, G.B. Pier, Y.A. Knirel, A.P. Anisimov & V.L. Motin. (2009) Yersinia pestis Live Vaccine with Improved Characteristics. Procedia in Vaccinology 1:1, pages 97-100.
Crossref
Crossref